I suspect all the recent interest in MVP is about the Continuous...

I suspect all the recent interest in MVP is about the Continuous Flow (CF) technology.
From VOX article, “The minute you talk about ventilators you need to talk about medications,” says Esther Choo, an associate professor of emergency medicine at Oregon Health & Science University. Choo says hospitals are already running out of medications like fentanyl, versed, propofol, and even neuromuscular blockades, what she calls “everyday bread and butter medications,” the drugs needed to induce and maintain sedation while on a ventilator. “Ventilators can’t really be used without these medications.”I suspect all the excitement in MVP is about the Continuous Flow technology.
Philip Capital increased the value of CF technology from $30M to $60M. Maybe its worth all of $60M and possibly more than that.